Literature DB >> 18537580

Heterotropic cooperativity in oxidation mediated by cytochrome p450.

Toshiro Niwa1, Norie Murayama, Hiroshi Yamazaki.   

Abstract

Cytochrome P450s (P450 or CYPs) comprise a superfamily of enzymes that catalyze the oxidation of a wide variety of xenobiotic chemicals. Although most of P450 inhibitors decrease the metabolic activities mediated by the corresponding P450 forms, unexpected phenomena, which are called as activation or heterotropic cooperativity, have been often observed. We summarize Michaelis-Menten constants (K(m)), maximal velocities (V(max)), V(max)/K(m) (intrinsic clearance) values, and/or metabolic activities for 22 activators and 24 substrates (30 reactions) mainly mediated by CYP3A4 among human P450 forms. Although an allosteric mechanism has been invoked to explain the cooperativity, the activation patterns or phenomena are dependent on substrates and selected enzyme sources in vitro. Interestingly, recent studies have been shown that human P450 forms other than CYP3A4, such as CYP1A2, CYP2C8, CYP2C9, CYP2D6, and CYP3A7, are also activated by some compounds, whereas there are few reports on CYP3A5. Several models describing interaction among substrates, effectors, and enzymes have been proposed, however, the detailed mechanism for the activation is still generally unknown even though some crystal structures have been shown. A few cases of the cooperativity of CYP3A in experimental animals have been presented, whereas the clinical significance of P450 cooperativity is still unclear. The collective findings provide fundamental and useful information for the activation of P450s by chemicals despite some contradictive kinetic parameters for the same reactions reported. To understand causal factor(s) and mechanism(s) for such different reports summarized here is still one of the hot research topics to be solved in current activation reactions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18537580     DOI: 10.2174/138920008784746364

Source DB:  PubMed          Journal:  Curr Drug Metab        ISSN: 1389-2002            Impact factor:   3.731


  18 in total

1.  Human liver microsomal cytochrome P450 3A enzymes involved in thalidomide 5-hydroxylation and formation of a glutathione conjugate.

Authors:  Goutam Chowdhury; Norie Murayama; Yusuke Okada; Yasuhiro Uno; Makiko Shimizu; Norio Shibata; F Peter Guengerich; Hiroshi Yamazaki
Journal:  Chem Res Toxicol       Date:  2010-06-21       Impact factor: 3.739

2.  Mixing apples and oranges: Analysis of heterotropic cooperativity in cytochrome P450 3A4.

Authors:  Daniel J Frank; Ilia G Denisov; Stephen G Sligar
Journal:  Arch Biochem Biophys       Date:  2009-06-26       Impact factor: 4.013

3.  CYP2E1 metabolism of styrene involves allostery.

Authors:  Jessica H Hartman; Gunnar Boysen; Grover P Miller
Journal:  Drug Metab Dispos       Date:  2012-07-17       Impact factor: 3.922

4.  ω-Hydroxylation of phylloquinone by CYP4F2 is not increased by α-tocopherol.

Authors:  Sherry M Farley; Scott W Leonard; Alan W Taylor; Marc Birringer; Katheryne Z Edson; Allan E Rettie; Maret G Traber
Journal:  Mol Nutr Food Res       Date:  2013-05-03       Impact factor: 5.914

5.  Structure-function relationships of inhibition of human cytochromes P450 1A1, 1A2, 1B1, 2C9, and 3A4 by 33 flavonoid derivatives.

Authors:  Tsutomu Shimada; Katsuhiro Tanaka; Shigeo Takenaka; Norie Murayama; Martha V Martin; Maryam K Foroozesh; Hiroshi Yamazaki; F Peter Guengerich; Masayuki Komori
Journal:  Chem Res Toxicol       Date:  2010-12-20       Impact factor: 3.739

6.  Comprehensive kinetic and modeling analyses revealed CYP2C9 and 3A4 determine terbinafine metabolic clearance and bioactivation.

Authors:  Dustyn A Barnette; Mary A Davis; Noah Flynn; Anirudh S Pidugu; S Joshua Swamidass; Grover P Miller
Journal:  Biochem Pharmacol       Date:  2019-10-09       Impact factor: 5.858

7.  Potential impact of cytochrome P450 3A5 in human liver on drug interactions with triazoles.

Authors:  Hiroshi Yamazaki; Minako Nakamoto; Makiko Shimizu; Norie Murayama; Toshiro Niwa
Journal:  Br J Clin Pharmacol       Date:  2010-06       Impact factor: 4.335

8.  Peripheral ligand-binding site in cytochrome P450 3A4 located with fluorescence resonance energy transfer (FRET).

Authors:  Dmitri R Davydov; Jessica A O Rumfeldt; Elena V Sineva; Harshica Fernando; Nadezhda Y Davydova; James R Halpert
Journal:  J Biol Chem       Date:  2011-12-22       Impact factor: 5.157

9.  Structural and mechanistic insights into the interaction of cytochrome P4503A4 with bromoergocryptine, a type I ligand.

Authors:  Irina F Sevrioukova; Thomas L Poulos
Journal:  J Biol Chem       Date:  2011-12-07       Impact factor: 5.157

10.  Cooperative effects for CYP2E1 differ between styrene and its metabolites.

Authors:  Jessica H Hartman; Gunnar Boysen; Grover P Miller
Journal:  Xenobiotica       Date:  2013-01-18       Impact factor: 1.908

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.